JP2023507740A5 - - Google Patents

Info

Publication number
JP2023507740A5
JP2023507740A5 JP2022537008A JP2022537008A JP2023507740A5 JP 2023507740 A5 JP2023507740 A5 JP 2023507740A5 JP 2022537008 A JP2022537008 A JP 2022537008A JP 2022537008 A JP2022537008 A JP 2022537008A JP 2023507740 A5 JP2023507740 A5 JP 2023507740A5
Authority
JP
Japan
Prior art keywords
seq
sequence
lcdr1
lcdr2
hcdr1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022537008A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507740A (ja
JP7600240B2 (ja
Filing date
Publication date
Priority claimed from GBGB1919019.8A external-priority patent/GB201919019D0/en
Application filed filed Critical
Publication of JP2023507740A publication Critical patent/JP2023507740A/ja
Publication of JP2023507740A5 publication Critical patent/JP2023507740A5/ja
Priority to JP2024200599A priority Critical patent/JP2025015730A/ja
Application granted granted Critical
Publication of JP7600240B2 publication Critical patent/JP7600240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022537008A 2019-12-20 2020-12-18 Psmaに結合する抗原結合ドメイン Active JP7600240B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024200599A JP2025015730A (ja) 2019-12-20 2024-11-18 Psmaに結合する抗原結合ドメイン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1919019.8 2019-12-20
GBGB1919019.8A GB201919019D0 (en) 2019-12-20 2019-12-20 Antigen-binding domain
PCT/GB2020/053289 WO2021123810A1 (en) 2019-12-20 2020-12-18 Antigen-binding domain binding to psma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024200599A Division JP2025015730A (ja) 2019-12-20 2024-11-18 Psmaに結合する抗原結合ドメイン

Publications (3)

Publication Number Publication Date
JP2023507740A JP2023507740A (ja) 2023-02-27
JP2023507740A5 true JP2023507740A5 (cg-RX-API-DMAC7.html) 2023-10-26
JP7600240B2 JP7600240B2 (ja) 2024-12-16

Family

ID=69322734

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022537008A Active JP7600240B2 (ja) 2019-12-20 2020-12-18 Psmaに結合する抗原結合ドメイン
JP2024200599A Pending JP2025015730A (ja) 2019-12-20 2024-11-18 Psmaに結合する抗原結合ドメイン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024200599A Pending JP2025015730A (ja) 2019-12-20 2024-11-18 Psmaに結合する抗原結合ドメイン

Country Status (8)

Country Link
US (1) US12496314B2 (cg-RX-API-DMAC7.html)
EP (1) EP4076509A1 (cg-RX-API-DMAC7.html)
JP (2) JP7600240B2 (cg-RX-API-DMAC7.html)
CN (1) CN114828879A (cg-RX-API-DMAC7.html)
AU (1) AU2020406862A1 (cg-RX-API-DMAC7.html)
CA (1) CA3161844A1 (cg-RX-API-DMAC7.html)
GB (1) GB201919019D0 (cg-RX-API-DMAC7.html)
WO (1) WO2021123810A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202007044D0 (en) * 2020-05-13 2020-06-24 Autolus Ltd Method
AU2023356326A1 (en) 2022-10-06 2025-03-27 Bicara Therapeutics Inc. Multispecific proteins and related methods
JP7855148B2 (ja) 2023-02-10 2026-05-07 アムニクス ファーマシューティカルズ, インコーポレイテッド 前立腺特異的膜抗原(psma)を標的とする組成物、並びにそれを作製及び使用するための方法
TW202442689A (zh) 2023-03-03 2024-11-01 美商亞森諾生物科學公司 靶向psma及ca9之系統

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003210060B2 (en) 2002-03-22 2010-02-25 Aprogen, Inc. Humanized antibody and process for preparing same
US8691771B2 (en) * 2010-05-21 2014-04-08 Merrimack Pharmaceuticals, Inc. Bi-specific fusion proteins for tissue repair
GB201206559D0 (en) 2012-04-13 2012-05-30 Ucl Business Plc Polypeptide
GB201405845D0 (en) 2014-04-01 2014-05-14 Ucl Business Plc Signalling system
GB201415347D0 (en) 2014-08-29 2014-10-15 Ucl Business Plc Signalling system
US20180016346A1 (en) 2015-01-08 2018-01-18 Kyowa Hakko Kirin Co., Ltd Bispecific antibody binding to trailr2 and psma
GB201501936D0 (en) 2015-02-05 2015-03-25 Ucl Business Plc Signalling system
GB201503133D0 (en) 2015-02-24 2015-04-08 Ucl Business Plc And Syncona Partners Llp Chimeric protein
CN109641037B (zh) * 2016-04-13 2022-09-06 西安奥瑞单抗生物技术有限公司 抗psma抗体及其用途
GB201607968D0 (en) 2016-05-06 2016-06-22 Crescendo Biolog Ltd Chimeric antigen receptor
KR20200130709A (ko) * 2018-03-06 2020-11-19 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 전립선-특이 막 항원 car 및 이의 사용 방법
BR112020018049A2 (pt) 2018-03-07 2020-12-29 Poseida Therapeutics, Inc. Composições de cartirina e métodos para uso
CN108640999B (zh) 2018-03-27 2021-08-13 广东万海细胞生物科技有限公司 一种靶向表达psma表面抗原的细胞的嵌合抗原受体
CN110526976A (zh) 2018-05-25 2019-12-03 深圳宾德生物技术有限公司 一种靶向psma的单链抗体、嵌合抗原受体t细胞及其制备方法和应用
CN110526984A (zh) 2018-05-25 2019-12-03 深圳宾德生物技术有限公司 一种靶向psma的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2022512132A (ja) 抗クローディン抗体及びそれらの使用
JP7785284B2 (ja) Cd38抗体とicam1抗体およびそれらの使用
JP2024109678A5 (cg-RX-API-DMAC7.html)
IL276830B2 (en) Anti-claudin 18.2 antibodies and uses thereof
JP2022058345A5 (cg-RX-API-DMAC7.html)
CN114502591A (zh) 靶向bcma的抗体、双特异性抗体及其用途
JP2021514664A5 (cg-RX-API-DMAC7.html)
SA521422116B1 (ar) أجسام مضادة لـ pd-1 جديدة
JP2020522281A5 (cg-RX-API-DMAC7.html)
JP2020522280A5 (cg-RX-API-DMAC7.html)
CN107151269A (zh) 一种pdl‑1抗体、其药物组合物及其用途
JP2023540526A5 (cg-RX-API-DMAC7.html)
IL273841B1 (en) Antibodies targeting cd137 and methods of use thereof
RU2017114968A (ru) Связывающие молекулы, а именно антитела, способные связываться с l1cam (cd171)
WO2016005950A1 (en) Immune-stimulating monoclonal antibodies against human interleukin-2
CN116041530A (zh) 多特异性抗体及其制备和使用方法
US20250179195A1 (en) Anti-flt3 antibodies and compositions
JP2020533965A5 (cg-RX-API-DMAC7.html)
CA3150030A1 (en) Methods for identification of antigen binding specificity of antibodies
JP2021512652A5 (cg-RX-API-DMAC7.html)
JP2021517459A5 (cg-RX-API-DMAC7.html)
JP2023509373A5 (cg-RX-API-DMAC7.html)
JP2020531003A5 (cg-RX-API-DMAC7.html)
JP2024533457A5 (cg-RX-API-DMAC7.html)
JP2024522075A5 (cg-RX-API-DMAC7.html)